Basking Biosciences, Inc. — Form D
Basking Biosciences, Inc. of Cary, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-15. The offering totals $55.0M, of which $27.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-15
- Form: D
- Accession: 0001864817-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55.0M
- Amount sold: $27.5M
- Remaining: $27.5M
- Investors: 11
- Date of first sale: 2023-10-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-497367
Issuer
- Name: Basking Biosciences, Inc.
- CIK: 0001824142
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 964 High House Rd #3268, Cary, NC, 27513
- Phone: 919-345-7933
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Richard Shea | Director | Cary, NC |
| Richard Shea | Executive Officer | Cary, NC |
| Richard Shea | Promoter | Cary, NC |
| Hannah Chang | Director | Cary, NC |
| Julia Owens | Director | Cary, NC |
| Julia Owens | Executive Officer | Cary, NC |
| Julia Owens | Promoter | Cary, NC |
| Aiden Aceves | Director | Cary, NC |
| David J Adair | Director | Cary, NC |
| Steve Gillis | Director | New York, NY |
| Ari Nowacek | Director | Cary, NC |
| Shahid Nimjee | Director | Cary, NC |
| Thomas Needham | Director | Cary, NC |
| Ryan Helon | Director | Columbus, OH |
| Dan Myers | Director | San Diego, CA |
| Bruce Sullenger | Director | Research Triangle Park, NC |
Other filings by this issuer (2)
More